• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病患者在接种新冠病毒信使核糖核酸疫苗后出现短暂性高血糖:一例报告

Transient Hyperglycemia in a Patient With Type 2 Diabetes After COVID-19 Messenger RNA Vaccination: A Case Report.

作者信息

Okon-Umoren Aniebietabasi, Yaphe Sean, Smith Andrea, Passalacqua Karla D, Budzynska Katarzyna

机构信息

Family Medicine, Henry Ford Health System, Detroit, USA.

Medical Education, Henry Ford Health System, Detroit, USA.

出版信息

Cureus. 2024 Jul 6;16(7):e63983. doi: 10.7759/cureus.63983. eCollection 2024 Jul.

DOI:10.7759/cureus.63983
PMID:39105031
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11299958/
Abstract

The development of new vaccines against the SARS-CoV-2 virus in response to the COVID-19 pandemic represents a milestone in the history of public health. However, due to the rapid development and short duration of these new vaccines, the full spectrum of side effects is not yet known. A 76-year-old man presented to the clinic for follow-up after being discharged from the emergency department for hyperglycemia. His medical history included well-controlled type 2 diabetes for two years, hypertension, and hyperlipidemia. He had recently noticed high home blood glucose readings over 400 mg/dL, and his hemoglobin A1c (mean 90-day glucose level) had increased from 6.5% to 12.6%. Notably, the patient reported having excellent health behaviors, including daily exercise, a closely monitored healthy diet, and regular blood glucose testing. After extensive endocrinology workup, the rapid change in blood glucose was thought to be due to his having recently received the COVID-19 messenger RNA (mRNA) vaccine. He was started on long- and short-acting insulin and a glucagon-like peptide-1 agonist (novel injectable type 2 diabetes medication), with improvement in blood glucose. He was tapered off all medications and remains on metformin 1,000 mg twice daily after one year.Whether the new COVID-19 mRNA vaccines directly incur hyperglycemia within certain groups of patients with diabetes is not known; thus, studies exploring the relationship between vaccine antigen binding and pancreatic function are needed.

摘要

为应对新冠疫情而研发的针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的新型疫苗,是公共卫生史上的一个里程碑。然而,由于这些新型疫苗研发迅速且使用时间较短,其副作用的全貌尚不清楚。一名76岁男性因高血糖从急诊科出院后到诊所进行随访。他的病史包括两年病情控制良好的2型糖尿病、高血压和高脂血症。他最近注意到家中血糖读数超过400mg/dL,糖化血红蛋白(平均90天血糖水平)从6.5%升至12.6%。值得注意的是,患者报告有良好的健康行为,包括每天锻炼、密切监测的健康饮食和定期血糖检测。经过广泛的内分泌检查,血糖的快速变化被认为是由于他最近接种了新冠信使核糖核酸(mRNA)疫苗。他开始使用长效和短效胰岛素以及一种胰高血糖素样肽-1激动剂(新型注射用2型糖尿病药物),血糖有所改善。一年后,他逐渐停用所有药物,目前仍每天服用两次1000mg二甲双胍。尚不清楚新型新冠mRNA疫苗是否会在某些糖尿病患者群体中直接引发高血糖;因此,需要开展研究探索疫苗抗原结合与胰腺功能之间的关系。

相似文献

1
Transient Hyperglycemia in a Patient With Type 2 Diabetes After COVID-19 Messenger RNA Vaccination: A Case Report.2型糖尿病患者在接种新冠病毒信使核糖核酸疫苗后出现短暂性高血糖:一例报告
Cureus. 2024 Jul 6;16(7):e63983. doi: 10.7759/cureus.63983. eCollection 2024 Jul.
2
Weekly Growth Hormone (Lonapegsomatropin) Causes Severe Transient Hyperglycemia in a Child with Obesity.每周给予生长激素(Lonapegsomatropin)治疗导致肥胖儿童出现严重的一过性高血糖。
Horm Res Paediatr. 2023;96(5):542-546. doi: 10.1159/000530522. Epub 2023 Apr 4.
3
Hyperglycemia Associated With Raynaud Phenomenon and Liver Dysfunction After COVID-19 Vaccination in Type 1 Diabetes Mellitus.1型糖尿病患者接种新冠疫苗后出现的与雷诺现象和肝功能障碍相关的高血糖症
AACE Clin Case Rep. 2023 Jun 2;9(4):131-5. doi: 10.1016/j.aace.2023.05.006.
4
Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.新冠肺炎合并糖尿病患者极高剂量胰岛素需求:一例报告。
BMC Endocr Disord. 2020 Oct 16;20(1):155. doi: 10.1186/s12902-020-00632-2.
5
COVID-19 Vaccine-Induced Rapid Progression of Prediabetes to Ketosis-Prone Diabetes Mellitus in an Elderly Male.新冠病毒疫苗诱导一名老年男性的糖尿病前期迅速进展为酮症倾向糖尿病
Cureus. 2022 Sep 6;14(9):e28830. doi: 10.7759/cureus.28830. eCollection 2022 Sep.
6
An Unanticipated Worsening of Glycemic Control Following a Mild COVID-19 Infection.轻度新冠病毒感染后血糖控制意外恶化
Cureus. 2022 Jun 24;14(6):e26295. doi: 10.7759/cureus.26295. eCollection 2022 Jun.
7
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
8
BNT162b2 mRNA COVID-19 Vaccine Does Not Impact the Honeymoon Phase in Type 1 Diabetes: A Case Report.BNT162b2信使核糖核酸新冠疫苗对1型糖尿病蜜月期无影响:一例报告
Vaccines (Basel). 2022 Jul 8;10(7):1096. doi: 10.3390/vaccines10071096.
9
Hyperglycemia Post-Influenza Vaccine in Patients With Diabetes.流感疫苗接种后糖尿病患者的高血糖症。
Ann Pharmacother. 2023 Jan;57(1):51-54. doi: 10.1177/10600280221098101. Epub 2022 Jun 2.
10
The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.新冠疫苗的快速研发和早期成功为加速癌症治疗机制带来了希望。
Arch Razi Inst. 2021 Mar;76(1):1-6. doi: 10.22092/ari.2021.353761.1612. Epub 2021 Mar 1.

本文引用的文献

1
Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes.血糖控制与接种疫苗的 2 型糖尿病患者的 SARS-CoV-2 突破感染有关。
Nat Commun. 2022 Apr 28;13(1):2318. doi: 10.1038/s41467-022-30068-2.
2
COVID-19 Vaccines and Hyperglycemia-Is There a Need for Postvaccination Surveillance?新冠疫苗与高血糖——是否需要进行疫苗接种后监测?
Vaccines (Basel). 2022 Mar 16;10(3):454. doi: 10.3390/vaccines10030454.
3
Type 1 diabetes mellitus following COVID-19 RNA-based vaccine.接种基于 RNA 的 COVID-19 疫苗后发生 1 型糖尿病。
J Diabetes Investig. 2022 Jul;13(7):1290-1292. doi: 10.1111/jdi.13781. Epub 2022 Mar 12.
4
Multiple early factors anticipate post-acute COVID-19 sequelae.多种早期因素预示着急性新冠病毒感染后会出现长期新冠症状。
Cell. 2022 Mar 3;185(5):881-895.e20. doi: 10.1016/j.cell.2022.01.014. Epub 2022 Jan 25.
5
Hyperglycemic Emergencies Associated With COVID-19 Vaccination: A Case Series and Discussion.与新冠病毒疫苗接种相关的高血糖急症:病例系列及讨论
J Endocr Soc. 2021 Sep 25;5(11):bvab141. doi: 10.1210/jendso/bvab141. eCollection 2021 Nov 1.
6
Exacerbation of hyperglycemia in patients with type 2 diabetes after vaccination for COVID19: Report of three cases.2型糖尿病患者接种新冠疫苗后高血糖加重:3例报告
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102151. doi: 10.1016/j.dsx.2021.05.024. Epub 2021 May 25.
7
Acute hyperglycaemic crisis after vaccination against COVID-19: A case series.2019冠状病毒病疫苗接种后急性高血糖危象:病例系列
Diabet Med. 2021 Nov;38(11):e14631. doi: 10.1111/dme.14631. Epub 2021 Jul 11.
8
COVID-19 Vaccine and Hyperosmolar Hyperglycemic State.新冠病毒疫苗与高渗高血糖状态
Cureus. 2021 Mar 26;13(3):e14125. doi: 10.7759/cureus.14125.
9
COVID-19 vaccines: modes of immune activation and future challenges.COVID-19 疫苗:免疫激活模式和未来挑战。
Nat Rev Immunol. 2021 Apr;21(4):195-197. doi: 10.1038/s41577-021-00526-x.
10
COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges.糖尿病患者的 COVID-19 疫苗接种:当前概念、不确定性与挑战
Diabetes Metab Syndr. 2021 Mar-Apr;15(2):505-508. doi: 10.1016/j.dsx.2021.02.026. Epub 2021 Feb 25.